IQVIA Holdings Inc. (IQV): Price and Financial Metrics


IQVIA Holdings Inc. (IQV): $201.74

4.48 (+2.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IQV POWR Grades


  • Growth is the dimension where IQV ranks best; there it ranks ahead of 95.42% of US stocks.
  • IQV's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • IQV's current lowest rank is in the Momentum metric (where it is better than 41.53% of US stocks).

IQV Stock Summary

  • IQV has a higher market value than 93.86% of US stocks; more precisely, its current market capitalization is $44,495,452,818.
  • IQV's current price/earnings ratio is 46.06, which is higher than 83.46% of US stocks with positive earnings.
  • The volatility of Iqvia Holdings Inc's share price is greater than that of only 16.84% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Iqvia Holdings Inc are NDAQ, WCN, NTR, CTSH, and ADM.
  • Visit IQV's SEC page to see the company's official filings. To visit the company's web site, go to www.iqvia.com.

IQV Valuation Summary

  • In comparison to the median Healthcare stock, IQV's EV/EBIT ratio is 79.18% higher, now standing at 52.5.
  • IQV's EV/EBIT ratio has moved up 34.5 over the prior 101 months.
  • IQV's price/sales ratio has moved up 2.7 over the prior 101 months.

Below are key valuation metrics over time for IQV.

Stock Date P/S P/B P/E EV/EBIT
IQV 2021-08-31 3.8 8.6 82.0 52.5
IQV 2021-08-30 3.9 8.7 82.6 52.8
IQV 2021-08-27 3.8 8.6 81.9 52.5
IQV 2021-08-26 3.8 8.6 81.6 52.3
IQV 2021-08-25 3.8 8.6 81.7 52.3
IQV 2021-08-24 3.8 8.5 81.1 52.0

IQV Growth Metrics

    Its 3 year revenue growth rate is now at 79.13%.
  • Its 5 year net cashflow from operations growth rate is now at 124.95%.
  • The 2 year price growth rate now stands at 44%.
IQV's revenue has moved up $3,341,000,000 over the prior 34 months.

The table below shows IQV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 13,874 2,942 966
2021-09-30 13,536 3,000 767
2021-06-30 12,931 2,730 607
2021-03-31 12,014 2,663 409
2020-12-31 11,359 1,959 279
2020-09-30 10,956 1,792 176

IQV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IQV has a Quality Grade of C, ranking ahead of 29.06% of graded US stocks.
  • IQV's asset turnover comes in at 0.558 -- ranking 289th of 563 Business Services stocks.
  • ISSC, MSTR, and TRUE are the stocks whose asset turnover ratios are most correlated with IQV.

The table below shows IQV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.558 0.332 0.104
2021-06-30 0.534 0.336 0.089
2021-03-31 0.500 0.337 0.070
2020-12-31 0.480 0.340 0.058
2020-09-30 0.469 0.340 0.051
2020-06-30 0.474 0.334 0.049

IQV Price Target

For more insight on analysts targets of IQV, see our IQV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $200.00 Average Broker Recommendation 1.33 (Strong Buy)

IQV Stock Price Chart Interactive Chart >

Price chart for IQV

IQV Price/Volume Stats

Current price $201.74 52-week high $285.61
Prev. close $197.26 52-week low $195.57
Day low $195.57 Volume 1,398,500
Day high $203.37 Avg. volume 1,159,318
50-day MA $223.26 Dividend yield N/A
200-day MA $245.44 Market Cap 38.19B

IQVIA Holdings Inc. (IQV) Company Bio


  IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of $49 Billion as of August 2021. As of 2017, IQVIA was reported to be one of the world's largest contract research organizations. (Source:Wikipedia)


IQV Latest News Stream


Event/Time News Detail
Loading, please wait...

IQV Latest Social Stream


Loading social stream, please wait...

View Full IQV Social Stream

Latest IQV News From Around the Web

Below are the latest news stories about Iqvia Holdings Inc that investors may wish to consider to help them evaluate IQV as an investment opportunity.

IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey

RESEARCH TRIANGLE PARK, N.C., February 24, 2022--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey Report.

Yahoo | February 24, 2022

2 ‘Perfect 10’ Stocks Worth Investing In

Earnings season is coming to an end, with some corporations still to report this week and next. The earnings results so far this reporting cycle have generally been encouraging, and momentum should remain high over the remainder of the reporting period. Despite better-than-expected earnings results, investors have become increasingly anxious as a result of market uncertainty over inflation, political disturbances, rate rises, supply-chain challenges, labor issues, and other factors. In such a market, TipRanks' Smart Score System, which allows investors to do a more thorough analysis of a firm before investing in it, may be beneficial.

Shalu Saraf on TipRanks | February 22, 2022

IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report

RESEARCH TRIANGLE PARK, N.C., February 22, 2022--IQVIA (NYSE:IQV) today published its 2021 Environmental, Social, and Governance (ESG) Report. The annual report highlights the significant efforts the company has made in advancing healthcare globally, increasing the diversity and engagement of its workforce, and reducing its global environmental footprint.

Yahoo | February 22, 2022

Jefferies Maintains Their Buy Rating on IQVIA Holdings (IQV)

In a report released yesterday, David Windley from Jefferies maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $293.00. The company's shares closed last Wednesday at $232.18. According to TipRanks.com, Windley is a top 100 analyst with an average return of 17.1% and a 70.8% success rate. Windley covers the Healthcare sector, focusing on stocks such as UnitedHealth, Catalent, and Humana. The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $293.09 average price target, representing a 28.3% upside.

Howard Kim on TipRanks | February 17, 2022

IQVIA Holdings – Consensus Indicates Potential 26.8% Upside

IQVIA Holdings with ticker code (IQV) have now 17 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 325 and 255 with the average target price sitting at 289.94. Given that the stocks previous close was at 228.64 this is indicating there is a potential upside of 26.8%. The day 50 moving average is 257.76 and the 200 moving average now moves to 251.16. The company has a market capitalisation of $44,356m. Company Website: https://www.iqvia.com [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $56,248m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solution...

DirectorsTalk | February 17, 2022

Read More 'IQV' Stories Here

IQV Price Returns

1-mo -16.90%
3-mo -11.62%
6-mo -24.77%
1-year -14.78%
3-year 49.91%
5-year 142.91%
YTD -28.50%
2021 57.47%
2020 15.96%
2019 33.00%
2018 18.66%
2017 28.73%

Continue Researching IQV

Here are a few links from around the web to help you further your research on Iqvia Holdings Inc's stock as an investment opportunity:

Iqvia Holdings Inc (IQV) Stock Price | Nasdaq
Iqvia Holdings Inc (IQV) Stock Quote, History and News - Yahoo Finance
Iqvia Holdings Inc (IQV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4919 seconds.